Table 2.
Groups | DNA (μg/100 mg wet tissue) | RNA (μg/100 mg wet tissue) | Total protein (mg/100 mg wet tissue) |
Control | 652.05 ± 17.12b | 378.51 ± 38.44b | 3.0 ± 0.19b |
NG100 | 688.84 ± 47.69 | 380.24 ± 48.96 | 2.43 ± 0.31 |
AA | 222.69 ± 18.78d | 167.35 ± 15.16d | 0.95 ± 0.08c |
NG25 + AA | 293.93 ± 33.49 | 208.68 ± 25.05 | 1.32 ± 0.13 |
NG50 + AA | 338.54 ± 21.44 | 250.06 ± 10.11 | 2.02 ± 0.46 |
NG100 + AA | 415.50 ± 41.51 | 298.34 ± 12.92 | 2.15 ± 0.27 |
MES + AA | 425.04 ± 38.23 | 307.44 ± 18.31 | 2.14 ± 0.26 |
Values are expressed as mean ± SE (n = 6) and analyzed using one way ANOVA followed by Newman-Keuls post hoc test.
P < 0.01 control vs acetic acid (AA);
P < 0.05,
P < 0.01 AA vs Naringenin (NG) 25 + AA, NG50 + AA, NG100 + AA or mesalazine (MES) + AA groups.